GI
MBX

GAMMA Investing’s MBX Biosciences MBX Stock Holding History

GAMMA Investing’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Buy
304
+5
+2% +$175 ﹤0.01% 2939
2026
Q1 		$8.93K Hold
299
– – ﹤0.01% 3123
2025
Q4 		$9.43K Hold
299
– – ﹤0.01% 3006
2025
Q3 		$5.23K Hold
299
– – ﹤0.01% 3158
2025
Q2 		$3.41K Buy
299
+279
+1,395% +$2.84K ﹤0.01% 3251
2025
Q1 		$148 Buy
+20
New +$211 ﹤0.01% 3769

Other funds holding MBX

AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

GAMMA Investing's MBX Position: Q2 2026 in Review

GAMMA Investing increased its MBX Biosciences (MBX) stake by 1.7% in Q2 2026, buying an estimated $175 and bringing the position to 304 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2939.

GAMMA Investing first reported a position in MBX in Q1 2025 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • GAMMA Investing held 304 shares of MBX Biosciences worth $16.8K as of Q2 2026.
  • GAMMA Investing bought 5 MBX Biosciences shares in Q2 2026, an estimated $175.
  • MBX Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2939 holding.
  • GAMMA Investing first reported a position in MBX Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 16 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.